Stability of atenolol, acebutolol and propranolol in acidic environment depending on its diversified polarity

Pharmaceutical Development and Technology

Volumn 11, Issue 4, 2006, Pages 409-416

  Krzek, Jan ^a   Kwiecień, Anna ^a   Zylewski, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acebutolol; Atenolol; Beta blockers' stability; Drug analysis; Kinetics of degradation process; Propranolol; TLC

Indexed keywords

ACEBUTOLOL; ACECOR; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NORMOCARD; PROPRANOLOL;

ACIDITY; ARTICLE; CHROMATOGRAPHY; DENSITOMETRY; DRUG DEGRADATION; DRUG STABILITY; HYDROLYSIS; HYDROPHILICITY; KINETICS; LIPOPHILICITY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THERMODYNAMICS; THIN LAYER CHROMATOGRAPHY;

ACEBUTOLOL; ADRENERGIC BETA-ANTAGONISTS; ATENOLOL; DRUG STABILITY; ELECTROSTATICS; HYDROCHLORIC ACID; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; KINETICS; PROPRANOLOL; TEMPERATURE; THERMODYNAMICS;

EID: 33845205138     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450600770106     Document Type: Article

References (23)

1. Amendola, L.; Molaioni, F.; Botre, F. Detection of beta-blockers in human urine by GC-MS-MS-EI: Perspectives for the antidoping control. J. Pharm. Biomed. Anal. 2000, 23 (1), 211-221.
2. Hemmersbach, P.; de la Torre, R. Stimulants, narcotics and β-blockers: 25 years of development in analytical techniques for doping control. J. Chromatogr. B, 1996, 687, 221-238.
3. Kintz, P.; Dumestre-Toulet, V.; Jamey, C.; Cirimele, V.; Ludes, B. Doping control of beta-adrenergic compounds through hair analysis. J. Forensic. Sci. 2000, 45, (1), 170-4.
4. Drayer, D.E. Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers. Pharmacotherapy 1987, 7 (4), 87-91.
5. Drayer, D.E. Clinical consequences of the lipophilicity and plasma protein binding of antiarrhytmic drugs and active metabolites in man. Ann. NY Acad. Sci. 1984, 432, 45-56.
6. Hjalmarson, A. Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter? Basic Res. Cardiol. 2000, 95, 141-145.
7. Tetko, I.V.; Tanchuk, V.Y.; Kasheva, T.N.; Villa, A.E. Internet software for the calculation of the lipophilicity and aqueous solubility of chemical compounds. J. Chem. Inf. Comput. Sci. 2001, 41 (2), 246-252.
8. Arendt, R.M.; Greenblatt, D.J. Liquid chromatographic retention of beta-adrenoceptor antagonists: an index of lipid solubility. J. Pharm. Pharmacol. 1984, 36 (6), 400-401.
9. Detroyer, A.; Vander Heyden, Y.; Carda-Broch, S.; Garcia-Alvarez-Coque, M.C.; Massart, D.L. Quantitative structure-retention and retention-activity relationships of blocking agents by micellar liquid chromatography. J. Chromatogr A, 2001, 912 (2), 211-221.
10. Gonzales, A.G.; Herrador, M.A.; Asuero, A.G. Hydrophobicity of β-adrenoceptor blocking agents: Study of correlations between retention in reversed-phase HPLC systems and octanol-water partition constants. Int. J. Pharm. 1995, 120, 215-220.
11. Gulyaeva, N.; Zaslavsky, A.; Lechner, P.; Chlenov, M.; Chait, A.; Zaslavsky, B. Relative hydrophobicity and lipophilicity of beta-blockers and related compounds as measured by aqueous two-phase partitioning, octanol-buffer partitioning and HPLC. Eur. J. Pharm. Sci. 2002, 17 (1/2), 81-93.
12. a values of beta-blockers by automated potentiometric titrations. J. Pharm. Biomed. Anal. 2000, 23, 459-468.
13. Zhao, Y.; Jona, J.; Chow, D.T.; Rong, H.; Semin, D.; Xia, X.; Zanon, R.; Spancake, C.; Maliski, E. High-throughput logP measurement using parallel liquid chromatography/ultraviolet/mass spectrometry and sample-pooling. Rapid Commun. Mass Spectrom. 2002, 16 (16), 1548-1555.
14. Andrisano, V.; Gotti, R.; Leoni, A.; Cavrini, V. Photodegradation studies on atenolol by liquid chromatography. J. Pharm. Biomed. Anal. 1999, 21, 851-857.
15. Tuszyńska, E.; Kwiatkowska, B.; Wieczorkowska, A.; Kaniewska, T. Investigation on chemical changes in overdue pharmaceuticals. Part I. Investigations on decomposition of atenolol. Chem. Anal. 1994, 39, 563.
16. Marton, S.; Hatem, A.; Csoka, G.; Racz, I. Preformulation study of atenolol-containing solutions I. The pH dependence of thermostability. Acta Pharm. Hung. 2001, 71 (2), 192-195.
17. Modamio, P.; Lastra, C.F.; Montejo, O.; Marino, E.L. Development and validation of liquid chromatography methods for the quantitation of propranolol, metoprolol, atenolol and bisoprolol: Application in solution stability studies. Int. J. Pharm. 1996, 130, 137-140.
18. El-Gindy, A.; Ashour, A.; Abel-Fattah, L.; Shabana, M. First derivative spectrophotometric, TLC-densitometric, and HPLC determination of acebutolol HCl in presence of its acid-induced degradation product. J. Pharm. Biomed. Anal. 2001, 24 (4), 527-534.
19. Bartolomei, M.; Bertocchi, P.; Ramusino, M.C.; Santucci, N.; Valvo, L. Physico-chemical characterisation of the modifications I and II of (R,S) propranolol hydrochloride: solubility and dissolution studies. J. Pharm. Biomed. Anal. 1999, 21, 299-309.
20. Constantinescu, T.; Popa, E. Propranolol purity and quality control. Rev. Chim. 1983, 34 (6), 548-553.
21. Henry, D.W.; Repta, A.J.; Smith, F.M.; White, S.J. Stability of propranolol hydrochloride suspension compounded from tablets. Am. J. Hosp. Pharm. 1986, 43 (6), 1492-1495.
22. Krzek, J.; Kwiecien, A. Application of densitometry for determination of beta-adrenergic-blocking agents in pharmaceutical preparations. J. Planar Chromatogr. 2005, 18, 313-318.
23. Carda-Broch, S.; Berthod, A. pH dependence of the hydrophobicity of β-blocker amine compounds measured by counter-current chromatography. J. Chromatogr. A 2002, 995, 55-66.